Format

Send to

Choose Destination
Ann N Y Acad Sci. 2013 Jul;1290:83-9. doi: 10.1111/nyas.12185.

Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?

Author information

1
Department of Human Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands.

Abstract

The number of people suffering from metabolic disorders is dramatically increasing worldwide. The need for new therapeutic strategies to combat this growing epidemic of metabolic diseases is therefore also increasing. In 2003, resveratrol was discovered to be a small molecule activator of sirtuin 1 (SIRT1), an important molecular target regulating cellular energy metabolism and mitochondrial homeostasis. Rodent studies have clearly demonstrated the potential of resveratrol to improve various metabolic health parameters. To date, however, only limited clinical data are available that have systematically examined the health benefits of resveratrol in metabolically challenged humans. This short review will give an overview of the currently available clinical studies examining the effects of resveratrol on obesity and type 2 diabetes from a human perspective.

KEYWORDS:

mitochondria; obesity; resveratrol; sirtuins; type 2 diabetes

PMID:
23855469
DOI:
10.1111/nyas.12185
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center